Chris Freeman

Chris Freeman, listed as senior executive, appears in our data through filings on Guardant Health, Inc. shares, published by SEC (Form 4). The record holds 40 filings, for trades running from 15 June 2022 to 1 October 2026.

The open-market record consists of 5 sales worth €9.4M, with no purchase. Outside the open market, there are 3 share grants and 32 option exercises. In 2026 alone, the filings show no purchases and 4 sales.

Most recently, on 2 October 2026, the filings show an option exercise in Guardant Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.